CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

PR Newswire Biotech
Original article

ALS Network Celebrates Final Congressional Passage of ACT for ALS Reauthorization Act

RegulatoryPositive
AI Analysis

Summary

The Accelerating Access to Critical Therapies (ACT) for ALS Reauthorization Act passed its final congressional vote and is heading to the President's desk before the September 30, 2026 expiration deadline.

Outcome Details

Bipartisan ACT for ALS Reauthorization Act passed final congressional vote and sent to President for signature

Importance:3/10
Sentiment:
0.70
legislationALSregulatorycongressional passagepatient advocacy

Read the original article

Published by PR Newswire Biotech on September 29, 2026 3:24 AM

Read Original